EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Welgene Biotech Co's enterprise value is NT$388.4 Mil.
Welgene Biotech Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was NT$322.5 Mil. Therefore, Welgene Biotech Co's EV-to-Revenue for today is 1.20.
The historical rank and industry rank for Welgene Biotech Co's EV-to-Revenue or its related term are showing as below:
ROCO:6661'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8 Med: 1.4 Max: 4.41
Current: 1.21
During the past 11 years, the highest EV-to-Revenue of Welgene Biotech Co was 4.41. The lowest was 0.80. And the median was 1.40.
ROCO:6661's EV-to-Revenue is ranked better than 78.97% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.66
vs ROCO:6661: 1.21
The historical data trend for Welgene Biotech Co's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Welgene Biotech Co's EV-to-Revenue
For the Diagnostics & Research subindustry, Welgene Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welgene Biotech Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Welgene Biotech Co's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Welgene Biotech Co's EV-to-Revenue falls into.
Welgene Biotech Co's current Enterprise Value is NT$388.4 Mil.
Welgene Biotech Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$322.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welgene Biotech Co (ROCO:6661) EV-to-Revenue Explanation
Welgene Biotech Co's share price for today is NT$20.55.
Welgene Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$13.47.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Welgene Biotech Co EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Welgene Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Welgene Biotech Co Ltd is engaged in providing clinical testing services. Its service and product offerings include next-generation sequencing service, microarray service, OPS diagnostics products, and Biovesicle products. The company also offers clinical testing agents and instruments.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:6661 has been successfully added to your 